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ge formsAbstract A new, reliable, sensitive and stability-indicating gradient HPLC method was introduced
for the simultaneous determination of two anti-hepatotoxic polyphenolic drugs (Silymarin and Cur-
cumin). The method was adapted to analyze both drugs in their dosage forms (tablets and capsules)
with no interference from common excipients. The photo diode array detector was used as a tool for
peak identiﬁcation and purity conﬁrmation especially that both drugs have several reported peaks.
In order to assess the stability-indicating power of the assay procedure, SIL and CUR were sub-
jected to different forced degradation studies: acidic, alkaline and neutral hydrolysis, photo-degra-
dation, oxidative degradation and dry heat. The developed method could efﬁciently separate the
parent drug peak from the degradation products peaks. The method was validated according to
the ICH guidelines with respect to linearity, detection and quantitation limits, accuracy, precision,
speciﬁcity, and robustness. Finally, the results of the proposed method for determination of SIL
were statistically compared to the ofﬁcial BP method and no signiﬁcant difference was found
between them.
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Silymarin (SIL) is an anti-hepatotoxic polyphenolic substance
isolated from the milk thistle plant, Silybum marianum, family
(Asteraceae) (United States Pharmacopeia, 2011). SIL (Sweet-
man, 2009), which is a mixture of ﬂavonolignans including the
isomers silibinin, silicristin, and silidianin -of which silibinin is
the major component- is claimed to be a free radical scavenger
and to have hepatoprotectant properties. It has been used ining Saud University.
indicating HPLC method for simultaneous determination of Silymarin
013), http://dx.doi.org/10.1016/j.arabjc.2013.06.021
2 M.A. Korany et al.various liver disorders, as well as to prevent hepatotoxicity
associated with poisoning (Sweetman, 2009).
Curcumin (CUR) which is a polyphenolic compound pres-
ent in the rhizomes of the turmeric (Curcuma longa Linn.) fam-
ily (Zingiberaceae) (Sweetman, 2009), has a wide biological
and pharmacological proﬁle. It is reported to have antioxidant
and hepatoprotective activity (Park et al., 2000). This com-
pound exhibits numerous biological activities including anti-
inﬂammatory, antiprotozoal, antibacterial, anti-HIV and
anti-cancer activities against several malignancies. Also, hep-
ato, neuroprotective, hypoglycemic, and antirheumatic effects
of curcumin were reported (Anand et al., 2007). The safety
of CUR at very high doses has been proved in various animal
and human studies (Anand et al., 2007). These studies led to
the approval of CUR as a ‘Generally Regarded as Safe’ ingre-
dient by the Food and Drug Administration (FDA) of the
United States of America, by the Natural Health Products
Directorate of Canada and the Expert Joint Committee of
the Food and Agriculture Organization/World Health Organi-
zation (FAO/WHO) on food additives (JECFA) (Basnet and
Skalko-Basnet, 2011).
The USP 34 (United states Pharmacopeia, 2011) mono-
graph of SIL (Powdered Milk Thistle Extract) describes a gra-
dient HPLC-UV method for its assay in pure form, in capsules
and in tablets, with a limit for resolution between Silybin A
and B not less than 1. However, the BP 2012 (British Pharma-
copoeia, 2012) monograph of SIL (Milk-thistle Fruit) de-
scribes also a gradient HPLC method for its analysis in pure
form, with a limit for resolution between Silibinin A and B
not less than 1.8.
Various methods are available for the determination of
SIL, including stability-indicating HPTLC method for quanti-
tative estimation of Silybin in bulk drug and pharmaceutical
dosage form (Parveen et al., 2010). HPLC and capillary elec-
trophoresis have been used for the determination of SIL from
dried fruits (Quaglia et al., 1999).
UPLC-UVmethod was reported for the simultaneous deter-
mination of active compounds in SIL (Liu et al., 2009). Several
reversed phase HPLC-UVmethods have been published for the
analysis of Silibinin in rat plasma and bile (Wu et al., 2007), in
the seed extract of some Milk Thistle (Radjabian et al., 2008),
in pharmaceutical preparations (Hadad et al., 2009), and in hu-
man plasma (Kosina and Bartek 2000). UPLC-MS methods
were also used to analyze and separate the active constituents
of the silymarin extract (Wang et al., 2010).
A differential pulse voltammetric method has been used for
the determination of SIL and vitamin E acetate mixture in
pharmaceuticals (Hassan et al., 2008).
Determination of SIL using spectrophotometry in bulk
drug and pharmaceutical formulations (Moin et al., 2010)
has also been found.
A survey of the literature showed that different analytical
techniques have been used for the analysis of CUR. CEmethods
have been used for the detection and determination of CUR
(Lechtenberg et al., 2004), also different TLC and HPTLC
methods have been reported for the simultaneous quantiﬁcation
and determination of Curcuminoids in Curcuma longa (Phatta-
nawasin et al., 2009). In addition, a stability-indicating HPTLC
method for the determination ofCUR in bulk drug and pharma-
ceutical formulations (Ansari et al., 2005) was published.
Several ﬂuorimetric methods have been used for the deter-
mination of CUR (Wang et al., 2008). NMR methods havePlease cite this article in press as: Korany, M.A. et al., A validated stability-
and Curcumin in various dosage forms. Arabian Journal of Chemistry (2also been reported for the rapid quantitation of CUR (Go¨ren
et al., 2009).
Different HPLCmethods have been described for the analy-
sis of CUR, such as HPLC methods with ﬂuorescence detector
which have been used for its quantiﬁcation in biological samples
(Schiborr et al., 2010). HPLC-MS methods have been used for
the assay of CUR in plasma (Yang et al., 2011).
HPLC-UV methods were also used, such as: HPLC meth-
ods for the quantitative determination of CUR in biological
ﬂuids (Han et al., 2011). Simultaneous determination of Curc-
uminoids in different types of extracts (Wichitnithad et al.,
2009) and in food products was done.(Nagappan et al., 2009).
A stability-indicating LC method dealing with the quantita-
tive determination of CUR in laboratory samples has been
found (Dandekar and Patravale, 2009).
A literature survey revealed that no analytical method has
been reported for the simultaneous analysis of SIL and CUR
and for their simultaneous analysis in the presence of their
forced degradation products.
In the present work, a new validated stability-indicating
HPLCmethod has been developed for the simultaneous analysis
of SIL andCUR.Furthermore, the different conditions for opti-
mization of the HPLC parameters for the simultaneous identiﬁ-
cation and determination of both drugs in their dosage forms
(tablets and capsules) were studied using HPLC- DAD. The
diode array detector which is an elegant part of the HPLC
instrument enhances the performance of the instrument and is
very efﬁcient in conﬁrming the peak purity of the several re-
ported peaks of SIL and CUR.
To validate the stability-indicating power of the developed
analytical method, SIL and CUR were subjected to forced deg-
radation studies including the effect of hydrolysis (acidic, alka-
line and neutral), oxidation, photolysis and dry heat. The
proposed method could effectively separate the drug peaks
from those of their degradation products.
2. Experimental
2.1. Materials and reagents
Silymarin and Curcumin were kindly supplied by EMITCO
Pharmaceuticals (Alexandria, Egypt). Methanol and acetonitrile
used were of HPLC grade and were obtained from LAB-SCAN
(UK). Other reagents were of analytical grade including: potas-
sium dihydrogen phosphate and orthophosphoric acid obtained
from LOBA-Chemie, NaOH, HCl and H2O2 obtained from EL-
NASR company-ADWIC for chemical industries (Egypt).
2.2. Pharmaceutical formulations
Legalex Tablets labeled to contain 70 mg Silymarin per tab-
let were manufactured by the Alexandria Company for Phar-
maceutical and Chemical Industries (Alexandria, Egypt).
Hepapro Capsules labeled to contain 100 mg Silymarin and
50 mg Curcumin per capsule were manufactured by EMITCO
Pharmaceuticals (Alexandria, Egypt).
2.3. Apparatus
A Waters HPLC system consisting of: Alliance e HPLC with a
2695 separation module consisting of a solvent management
module, a sample management module and a column oven.indicating HPLC method for simultaneous determination of Silymarin
013), http://dx.doi.org/10.1016/j.arabjc.2013.06.021
A validated stability-indicating HPLC method for simultaneous determination 3Empower 2 chromatography data software for the recording
and integration of the chromatograms. The detector was a
PDA (Photodiode Array) absorbance detector (2998 Waters
detector).
The column used: Waters X-bridge (C18) column, pack-
ing material: Hybrid particle, dimension: (250X 4.6 mm i.d.)
and Particle size: 5 lm.
2.4. Stock standard solutions preparation
2.4.1. Preparation of stock Silymarin and Curcumin standard
solutions
Stock solutions were prepared by dissolving SIL or CUR in
methanol to obtain solutions having concentrations of 1 and
0.5 mg mL1, respectively. The solutions were stable in a
refrigerator at 5 C for a week.
2.4.2. Preparation of stock Silymarin and Curcumin solutions
for forced degradation
Stock solutions were prepared by dissolving SIL or CUR in
methanol to obtain solutions having a concentration of 2.5
and 1.25 mg mL1, respectively. The solution was stable in a
refrigerator at 5 C for a week.
2.5. Standard solutions preparation
2.5.1. Preparation of working Silymarin and Curcumin standard
solutions
Working SIL and CUR standard solutions were prepared by
accurately transferring different volumes (3–7 mL) of each
stock solution into 20-mL volumetric ﬂasks, completing to vol-
ume with a diluting solvent composed of 0.05 M KH2PO4
solution pH 2.3: methanol (65:35 V/V) to obtain different
working standard solutions of SIL and CUR in the range of
(0.15–0.35) and (0.075–0.175) mg mL1, respectively. These
solutions were directly injected into the HPLC system.
2.5.2. Preparation of working Silymarin and Curcumin standard
mixture solution
Working standard mixture solution of SIL and CUR was pre-
pared by accurately transferring a volume of 5 mL from each
corresponding stock solution, into a 20-mL volumetric ﬂask.
The volume was completed with diluting solvent to obtain a ﬁ-
nal concentration of 0.25 and 0.125 mg mL1 of SIL and
CUR, respectively and the solution was mixed well, and then
injected directly into the HPLC system.
2.6. Chromatographic conditions
Column: Waters X-bridge (C18) column.
Packing material: Hybrid particle.
Dimension: (250 · 4.6 mm i.d) and Particle size: 5 lm.
Mobile phase: Gradient elution of mobile phase compo-
nents A, B and C, table (1).
Mobile phase A: 0.05 M KH2PO4 adjusted at pH 2.3.
Mobile phase B: Methanol.
Mobile phase C: Acetonitrile.
Flow rate: 1 mL/min.
Temperature: Column oven was adjusted at 30 C.Please cite this article in press as: Korany, M.A. et al., A validated stability-
and Curcumin in various dosage forms. Arabian Journal of Chemistry (2Detection wavelength: Using photodiode array detector set
at 288 nm.
Injection volume: 20 lL.
2.7. Analysis of Silymarin and Curcumin different dosage forms
2.7.1. Preparation of test Legalex Tablets solution
Test solution was prepared by weighing 20 tablets of Legalex
(labeled to contain 70 mg of SIL per one tablet) to determine
their average weight, then an amount of powdered tablets
equivalent to 100 mg of SIL was transferred into a 100-mL vol-
umetric ﬂask, 40 mL of methanol was added, then the solution
was sonicated for 15 min and the volume was completed with
methanol, to obtain a stock test solution having a concentra-
tion of 1 mg mL1. The stock test solution was ﬁltered; 5 mL
was transferred into a 20-mL volumetric ﬂask and completed
to volume with diluting solvent, mixed well to obtain a work-
ing test solution of ﬁnal concentration 0.25 mg mL1. This
solution was injected directly into the HPLC system.
2.7.2. Preparation of test Hepapro Capsules solution
Test solution was prepared by emptying the content of 20 cap-
sules of Hepapro (labeled to contain 100 mg of SIL and
50 mg of CUR per capsule) to determine their average weight.
Then an amount equivalent to 100 mg of SIL and 50 mg of
CUR was transferred into a 100-mL volumetric ﬂask, and
then preceded as under the Section 2.7.1, in order to obtain
a working test solution of ﬁnal concentration 0.25 and
0.125 mg mL1 of SIL and CUR, respectively.
2.8. Forced degradation study
2.8.1. Acidic hydrolysis
A volume of 10 mL of the stock SIL or CUR solution for
forced degradation was mixed with 10 mL of 2 N HCl into a
250-mL conical ﬂask, heated in a water bath adjusted at
70 C for four hours and cooled. Then the solution was neu-
tralized with 2 N NaOH, transferred quantitatively into a
100-mL volumetric ﬂask, completed to volume with diluting
solvent and mixed well to give a ﬁnal concentration of
0.25 mg mL1 of SIL or 0.125 mg mL1 of CUR. Finally these
solutions were ﬁltered and injected into the HPLC system
using chromatographic conditions previously stated.
2.8.2. Alkaline hydrolysis
A volume of 10 mL of the stock SIL or CUR solution for
forced degradation was mixed with 10 mL of 2 N NaOH into
a 250-mL conical ﬂask, heated in a water bath adjusted at
70 C for 4 h and cooled. Then the solution was neutralized
with 2 N HCl, and the procedure was continued as described
under Section 2.8.1.
2.8.3. Neutral hydrolysis
A volume of 10 mL of the stock SIL or CUR solution for
forced degradation was mixed with 10 mL of distilled water
into a 250-mL conical ﬂask, heated in a water bath adjusted
at 70 C for four hours and cooled, transferred quantitatively
into a 100-mL volumetric ﬂask, then the procedure was contin-
ued as described under Section 2.8.1.indicating HPLC method for simultaneous determination of Silymarin
013), http://dx.doi.org/10.1016/j.arabjc.2013.06.021
Figure 1 HPLC chromatograms of working standard Silymarin solution (0.25 mg mL1) using methanol percentage of 35% (a) and
65% (b) in the mobile phase.
4 M.A. Korany et al.2.8.4. Photo-degradation
A volume of 10 mL of the stock SIL or CUR solution for
forced degradation was mixed with 10 mL of distilled water
into a 250-mL conical ﬂask, exposed to sunlight for 8 h, trans-
ferred quantitatively into a 100-mL volumetric ﬂask, then the
procedure was continued as described under Section 2.8.1.
2.8.5. Oxidative degradation
A volume of 10 mL of the stock SIL or CUR solution for
forced degradation was mixed with 10 mL of 30% H2O2 solu-
tion into a 250-mL conical ﬂask, heated in a water bath ad-
justed at 70 C for four hours, cooled, transferred
quantitatively into a 100-mL volumetric ﬂask, then the proce-
dure was continued as described under Section 2.8.1.
2.8.6. Dry heat
500 mg of SIL or CUR working standard was weighed into a
petri dish, inserted in an oven previously adjusted to 105 C,
left for 4 h then cooled. An amount of the powder was weighed
and dissolved in methanol to obtain a solution having a con-
centration of 2.5 mg mL1 of SIL or 1.25 mg mL1 of CUR.
A volume of 10 mL from each previous solution was trans-
ferred into a 100-mL volumetric ﬂask and the volume was
completed with a diluting solvent to obtain solutions having ﬁ-Please cite this article in press as: Korany, M.A. et al., A validated stability-
and Curcumin in various dosage forms. Arabian Journal of Chemistry (2nal concentrations of 0.25 mg mL1 and 0.125 mg mL1 for
SIL and CUR, respectively. Finally these solutions were ﬁl-
tered and injected into HPLC system using chromatographic
conditions previously stated.
3. Results and discussion
3.1. Optimization of chromatographic conditions
3.1.1. Effect of the column type
The effect of different column types (packing material) on the
simultaneous separation and determination of SIL and CUR
peaks was studied using four different C18 columns (Symme-
try, Symmetry sheild, Zorbax XBD and X-bridge column).
This was done using a mobile phase composed of MeOH:
phosphate buffer pH 2.3 in a ratio of 4:6 (v/v) and the most
suitable separation between SIL peaks with the highest resolu-
tion between Silybin A and B peaks was achieved using the X-
bridge column.
3.1.2. Effect of mobile phase mode
The effect of mobile phase mode (isocratic and gradient) on
the simultaneous separation and determination of SIL and
CUR peaks was studied. Isocratic elution was ﬁrstly triedindicating HPLC method for simultaneous determination of Silymarin
013), http://dx.doi.org/10.1016/j.arabjc.2013.06.021
Table 1 Gradient elution of mobile phase for the chromatographic separation of Silymarin, Curcumin and their forced degradation
products.
Time 0.05 M KH2PO4 pH 2.3% (V/V) Methanol% (V/V) Acetonitrile% (V/V)
0–3 65 35 –
3–12 65ﬁ 55 35ﬁ 45 –
12–15 55ﬁ 50 45ﬁ 50 –
15–24 50 50 –
24–24.1 50ﬁ 55 50ﬁ 0 0ﬁ 45
24.1–35 55 – 45
35–35.1 55ﬁ 65 0ﬁ 35 45ﬁ 0
35.1–38 65 35 –
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Figure 2 HPLC chromatogram of standard mixture solution of Silymarin 0.25 mg mL1 and Curcumin 0.125 mg mL1 obtained by the
proposed HPLC method.
Table 2 Chromatographic characteristics of Silymarin, and Curcumin peaks by the proposed HPLC method.
tr
a Nb K0c d Rs
e Tf
f
Silybin A 19.38 49375 6.75 0.89
Silybin B 20.30 38290 7.11 1.05 2.45 0.92
Bisdemethoxycurcumin 34.94 179064 11.29 – – 0.83
Demethoxycurcumin 35.77 102910 13.30 1.03 2.07 0.80
Curcumin 36.71 89022 13.68 1.03 2.07 0.80
a Retention time, in minutes.
b Number of theoretical plates.
c Capacity factor.
d Selectivity.
e Resolution, between each two successive peaks.
f Tailing factor.
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6 M.A. Korany et al.using different MeOH ratios with the phosphate buffer pH 2.3
(Fig. 1). Low MeOH ratio resulted in an increase in the reten-
tion time of the peaks more than 55 min and this was unsuit-
able for HPLC, while increasing the MeOH ratio resulted in
overlapping of SIL peaks. As a result, a gradient elution was
selected (Table 1).(a)
(b)
(d)
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Figure 3 Spectra of Silybin A (a), as a representative example of c
derivative spectra (b), 2nd derivative spectra (c), 3rd derivative spectr
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The effect of temperature of the column on the separation
of SIL peaks was studied. Upon using a temperature of
25 C, the retention time of SIL peaks was considered high
and inapplicable for HPLC separation while at a tempera-
ture of 40 C, the resolution between Silybin A and B was(c)
(e)
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A validated stability-indicating HPLC method for simultaneous determination 7not suitable and did not conform to both USP 34 (United
states Pharmacopeia, 2011) and BP (British Pharmacopoeia,
2012) 2012 monographs. However, at a temperature of
30 C, SIL peaks eluted at shorter retention times compared248.4
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Figure 4 Spectra of bisdemethoxycurcumin (a), as a representative e
intervals, 1st derivative spectra (b), 2nd derivative spectra (c), 3rd der
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8 M.A. Korany et al.3.1.4. Selection of phosphate buffer pH
The pH of phosphate buffer was selected according to buffer
capacity of phosphate which resulted in more resistance to
pH changes and this, in turn, led to less variation in retention
times and to a more robust method.
3.2. HPLC method development
Gradient elution was used for the simultaneous determination
of SIL and CUR (Fig. 2) with good chromatographic charac-
teristics, Table 2. The gradient elution was beneﬁcial in the sep-
aration of high number of peaks belonging to both drugs (SIL
and CUR) in a relatively short run time which greatly savesS
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Figure 5 Peak purity plots of Silymarin peaks, SIL 1-4 (a–d)
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ical plates (N).
The HPLC method achieved a good resolution between
Silybin A and B (good resolution and selectivity values) which
is conformed to both USP and BP monograph requirements,
and a good resolution between the three CUR peaks (Curcu-
min, demethoxycurcumin and bisdemethoxycurcumin) within
a reasonable run time (suitable capacity factors). In addition,
high column efﬁciency was indicated from the large number
of theoretical plates of both SIL and CUR peaks. The degree
of peak symmetry was also evaluated using the tailing factor
which did not exceed the critical value (1.2) indicating an
acceptable degree of peak asymmetry. (Table 2 and Fig. 2).D
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Fig. 2 shows nine SIL peaks and three CUR peaks well sepa-
rated from each other and within suitable retention times. For
SIL, seven SIL peaks were separated and named SIL1 to SIL
7 with the two peaks of Silybin A and B (Silibinin A and B) iden-
tiﬁed as themain two peaks in SIL(United states Pharmacopeia,
2011; British Pharmacopoeia, 2012; Liu et al., 2009; Radjabian
et al. 2008 and Hadad et al., 2009). The three CUR peaks were
separated and identiﬁed as bisdemethoxycurcumin, demethoxy-
curcumin and Curcumin, respectively (Lechtenberg et al., 2004;
Phattanawasin et al., 2009). In the present work the chromato-
graphic peak purity was assessed as follows:Purity
Auto Threshold
AU
0.0020
0.0022
0.0024
0.0026
0.0028
0.0030
Minutes
34.65 34.70 34.75 34.80 34.85 34.90
Purity
Auto Threshold
AU
0.0020
0.0025
0.0030
0.0035
0.0040
0.0045
0.0050
0.0055
Minutes
35.25 35.30 35.35 35.40 35.45 35.50 35.55 35.60 35.65
Purity
Auto Threshold
AU
0.000
0.002
0.004
0.006
0.008
0.010
0.012
0.014
0.016
Minutes
36.05 36.10 36.15 36.20 36.25 36.30 36.35 36.40 36.45 36.50 36.55
(a)
(b)
(c)
Figure 6 Peak purity plots of Curucmin peaks, bisdemethoxycurcu
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The spectra (A vs k), D1, D2, D3 and D4 of Silybin A, Silybin B,
bisdemethoxycurcumin, demethoxycurcumin and Curcumin,
were recorded at different time intervals across their chromato-
graphic peaks obtained from the DAD detector indicating the
purity of the peaks (Figs. 3 and 4)3.3.2. Use of peak purity plot
The peak purity plot in which the purity angle was found to be
less than the purity threshold, gave additional conﬁrmation of
the purity of the nine SIL peaks and the three CUR peaks
(Figs. 5 and 6).C
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Table 3 Evaluation of the accuracy for the determination of Silymarin (SIL) and Curcumin (CUR) by the proposed HPLC method
according to ICH guidelines.
Nominal value (mg mL1) Mean recovery%a ± SD Grand meanb Pooled SDc S.Ed
SIL
0.20 100.20 ± 0.408 100.05% 0.946 0.315
0.25 100.02 ± 1.27
0.30 99.92 ± 0.950
CUR
0.10 100.51 ± 0.618 100.12% 0.883 0.294
0.125 100.26 ± 1.21
0.15 99.58 ± 0.696
a Mean of %recovery of the three different solutions at each concentration level for each drug.
b Mean of recovery of the three different concentration levels.
c Pooled standard deviation of all recoveries for the three different concentration levels.
d Standard error of the mean.
Table 4 Evaluation of the intra-day precision for the deter-
mination of Silymarin and Curcumin by the proposed HPLC
method according to ICH guidelines.
Assay number Mean recovery%a
Silymarin Curcumin
1 101.81 101.33
2 101.70 101.17
3 102.01 101.96
4 101.75 102.34
5 101.62 101.66
6 101.34 101.65
Mean%b 101.71 101.69
SDc 0.222 0.424
RSD%d 0.218 0.417
a Recovery of each individual assay, for a concentration of
0.25 mg mL1 Silymarin and 0.125 mg mL1 Curcumin.
b The mean of all recoveries of all determinations (n= 6).
c Standard deviation of the recoveries of all determinations.
d Percentage relative standard deviation of all determinations.
Table 5 Evaluation of the inter-day precision for the deter-
mination of Silymarin (SIL) and Curcumin (CUR) by the
proposed HPLC method according to ICH guidelines.
Mean recovery%a
Day SIL CUR
1 100.33 101.45
2 100.70 101.14
3 99.99 100.24
Grand mean%b 100.34 100.94
Pooled SDc 0.869 0.457
RSD%d 0.866 0.453
a Mean recovery, for a concentration of 0.25 mg mL1 Silymarin
and 0.125 mg mL1 Curcumin for each day.
b The grand mean of recoveries of all determinations in the three
different days.
c Pooled standard deviation of all recoveries for the three dif-
ferent days.
d Percentage relative standard deviation of all determinations.
10 M.A. Korany et al.3.4. Method validation
The method was validated according to ICH guidelines (Inter-
national Conference on Harmonization, 2005). The following
validation characteristics were addressed.
3.4.1. Linearity
Peak area (sum of all nine peaks of SIL and sum of three peaks
of CUR) against concentration curves were obtained for both
SIL and CUR in the ranges of 0.15–0.35 and 0.075–0.175
mg mL1, respectively. An excellent linearity (r= 0.9999 for
SIL and 0.9997 for CUR) was obtained with regression equa-
tions of y= 27196878x  115236 and
y= 10134416x+ 12168, for SIL and CUR, respectively.
Good regression lines (Armitage and Berry, 1994) showing
high (r) values with low (Sy/x) values of 28,486 and 11,996
for SIL and CUR, respectively were obtained.
3.4.2. Detection and quantitation limits
Limits of detection (LOD) and quantitation (LOQ) were calcu-
lated by using the residual standard deviation of the regressionPlease cite this article in press as: Korany, M.A. et al., A validated stability-
and Curcumin in various dosage forms. Arabian Journal of Chemistry (2line (Sy/x) of the calibration curve and its slope (b). LOD is
equal to (yB + 3 SB) where yB is the value of the calculated
intercept and SB is the Sy/x, while LOQ is equal to (yB + 10
SB) (Miller and Miller, 2005). LOD and LOQ calculated by
this statistical method were 0.0031, 0.0035 and 0.0104,
0.0118 mg mL1 for SIL and CUR, respectively.
3.4.3. Accuracy
The accuracy of the proposed HPLC method was evaluated by
analyzing three laboratory prepared solutions of a standard
mixture of SIL and CUR (added to placebo) at three different
concentration levels within the working linearity range of both
drugs. Accuracy was expressed as the recovery% (Interna-
tional Conference on Harmonization, 2005) and standard er-
ror for SIL and CUR. Table 3 illustrates the method
accuracy for SIL and CUR with satisfactory recovery%. Small
values for both standard error and pooled standard deviation
were obtained.
3.4.4. Precision
The precision of an analytical method gives information on the
random errors. It expresses the closeness of agreement between
a series of measurements obtained from multiple sampling ofindicating HPLC method for simultaneous determination of Silymarin
013), http://dx.doi.org/10.1016/j.arabjc.2013.06.021
Table 6 Evaluation of the robustness for the determination of Silymarin and Curcumin by the proposed HPLC method according to
ICH guidelines.
Parameters Recovery%a % Change b Mean recovery%± SDc RSD%d
SIL CUR SIL CUR SIL CUR SIL CUR
pH of phosphate buﬀer
(2.2, 2.3 and 2.4)
2.2 100.84 102.05 0.069% 0.860% 100.57 ± 0.535 101.52 ± 0.463 0.532 0.456
2.3* 100.91 101.18 – –
2.4 99.95 101.34 0.951% 0.158%
Temperature
(29, 30 and 31 C)
29 100.12 100.25 0.250% 0.516% 99.75 ± 0.448 100.68 ± 0.397 0.449 0.394
30* 99.87 100.77 – –
31 99.25 101.03 0.621% 0.258%
* Analytical pH and temperature of the proposed method.
a The recovery of the Silymarin and Curcumin samples at each pH value and temperature for a concentration of 0.25 mg mL1 Silymarin and
0.125 mg mL1 Curcumin.
b % change in the recovery from the analytical point.
c The mean of recoveries at different pH values and temperatures ± their standard deviation
d Percentage relative standard deviation at the three pH values and temperatures.
Figure 7 HPLC chromatograms of a working standard solution of Silymarin 0.25 mg mL1 after oxidative degradation with 30% H2O2
(a) and alkaline hydrolysis with 2 N NaOH (b).
A validated stability-indicating HPLC method for simultaneous determination 11the same homogenous sample under prescribed conditions
(International Conference on Harmonization, 2005). It is di-
vided into repeatability (intra-day precision), intermediate pre-
cision (inter-day precision).
3.4.4.1. Repeatability (intra-day). The intra-day variation for
the determination of SIL and CUR was carried out by analyz-
ing dosage form sample solutions (Hepapro Capsules) pre-Please cite this article in press as: Korany, M.A. et al., A validated stability-
and Curcumin in various dosage forms. Arabian Journal of Chemistry (2pared at 100% of test concentration stated in the method
(0.25, 0.125 mg mL1 of SIL and CUR, respectively) using
the analytical procedure, within the same laboratory, using
the same analyst, with the same equipment, on the
same day. Repeatability was assessed using six determinations
each injected twice, by calculating the RSD% values
obtained by repeating the assay six times on the same day
(Table 4).indicating HPLC method for simultaneous determination of Silymarin
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12 M.A. Korany et al.3.4.4.2. Intermediate precision (Inter-day). The inter-day preci-
sion for the determination of SIL and CUR was carried out
as described under repeatability but on three consecutive
days, each of two determinations (n= 6). Precision was ex-
pressed as the percentage relative standard deviation (%
RSD) for SIL and CUR (Table 5). The data indicated a
good agreement among the individual test results. The crite-
rion for intra-day and inter-day precisions demands a RSD
less than 2%.
3.4.5. Robustness
Robustness of the proposed method was evaluated by analyz-
ing SIL and CUR dosage form (Hepapro Capsules) at the
same concentration level used under precision at intentionalFigure 8 HPLC chromatograms of a working standard solution of
neutral hydrolysis with H2O (b) and photo-degradation with sunlight
Please cite this article in press as: Korany, M.A. et al., A validated stability-
and Curcumin in various dosage forms. Arabian Journal of Chemistry (2slight variation of the selected parameters indicated in Table 6.
The RSD% of the recovery obtained by analyzing the same
sample after introducing small deliberate changes in the meth-
od parameters was calculated and was found to be less than
2% indicating the robustness of the method (Table 6).
3.4.6. Speciﬁcity
The simultaneous determination of SIL and CUR in their
pharmaceutical preparations revealed that the normally
existing excipients and additives did not interfere in the applied
HPLC method. So, pharmaceutical preparations containing
SIL (Legalex Tablets) and pharmaceutical preparations
containing both SIL and CUR (Hepapro Capsules) were suc-
cessfully analyzed by the proposed HPLC method.Curcumin 0.125 mg mL1 after acid hydrolysis with 2 N HCl (a)
(c).
indicating HPLC method for simultaneous determination of Silymarin
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Figure 9 HPLC chromatograms of a working standard solution of Curcumin 0.125 mg mL1 after oxidative degradation with 30%
H2O2 (a) and alkaline hydrolysis with 2 N NaOH (b).
Table 7 Analysis of Silymarin and Curcumin in different
dosage forms by the external standard method.
Dosage form Recovery%a Mean recovery%± RSD%b
Legalex tablets Silymarin 100.19 ± 0.374
100.45
99.92
Hepapro Capsules Silymarin 100.49 ± 0.380
100.76
100.22
Curcumin 100.78 ± 0.603
100.35
101.21
a The recovery% of the duplicate determinations of a concen-
tration of 0.25 mg mL1 of Silymarin in Legalex Tablets and
Hepapro Capsules dosage forms and of a concentration of
0.125 mg mL1 of Curcumin in Hepapro Capsules.
b The mean recovery%±RSD% of duplicate determinations.
Table 8 Analysis of Silymarin tablets dosage form by the
proposed method and the reference method (BP method).
Number of assay Reference method Proposed method
Recovery%a Recovery%a
1 100.72 101.11
2 101.88 102.11
3 101.55 100.95
4 101.64 100.75
5 99.98 100.29
Mean recovery%b 101.15 101.04
SDc 0.788 0.672
Variance 0.621 0.452
RSD%d 0.780 0.665
F-test* 1.374
t-test* 0.238
a The recovery% of a concentration of 0.25 mg mL1 of the
Silymarin in Legalex Tablets dosage form.
b The mean of all recoveries of all determinations (n= 5).
c Standard deviation of the recoveries of all determinations.
d Percentage relative standard deviation of all determinations.
* Theoretical values for F and t tests at p= 0.05 are 6.388 at (4, 4)
degree of freedom and 2.31 at (8) degree of freedom, respectively.
A validated stability-indicating HPLC method for simultaneous determination 133.4.7. Forced degradation study
The effect of the presence of different forced degradation prod-
ucts on the purity of SIL and CUR peaks was studied and the
method was found to be stability-indicating.Please cite this article in press as: Korany, M.A. et al., A validated stability-indicating HPLC method for simultaneous determination of Silymarin
and Curcumin in various dosage forms. Arabian Journal of Chemistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.06.021
14 M.A. Korany et al.3.4.7.1. Silymarin. The peaks of SIL were not affected by acidic
and neutral hydrolysis, photo-degradation, oxidative degrada-
tion or dry heat. Their peak areas did not change. For the oxi-
dative degradation, a peak attributed to oxygen eluted at
2.708 min, far from the retention time of both SIL peaks and
CUR peaks (Fig. 7a).
For the alkaline hydrolysis, the peaks of SIL were totally
destroyed with the appearance of seven other foreign degrada-
tion peaks which eluted far from the retention times of both
SIL peaks and CUR peaks (Fig. 7b). In all cases of the forced
degradation, the purity angles of SIL peaks were found to be
smaller than purity threshold which indicated the purity of
these peaks.
3.4.7.2. Curcumin. For the acidic and neutral hydrolysis,
photo-degradation and oxidative degradation, the peaks of
CUR were partially degraded as the peak areas of CUR were
decreased by 43%, 26%, 37% and 41%, respectively with the
appearance of different degradation product peaks eluted far
from the retention time of both SIL and CUR peaks (Figs
8a–c). For the oxidative degradation, in addition to the degra-
dation product peaks, the oxygen peak eluted far from the
retention time of both SIL and CUR peaks (Fig. 9a).
For the alkaline hydrolysis, the peaks of CUR were nearly
completely destroyed as the peak areas of CUR were decreased
by 92% with the appearance of ﬁve degradation products
peaks eluted far from the retention times of both SIL and
CUR peaks (Fig. 9b).
For the dry heat, the peaks of CUR were not affected and
their peak areas did not change. In all cases of forced degrada-
tion, the purity angles of CUR peaks were smaller than the
purity threshold which indicates the purity of these peaks.
3.5. Analysis of pharmaceutical formulation
Using the proposed HPLC method, determination of SIL in its
dosage form (tablets) and of both SIL and CUR in their dos-
age form (capsules) was carried out using the external standard
method. SIL was analyzed in different dosage forms including:
Legalex Tablets and Hepapro Capsules while CUR was
analyzed in Hepapro Capsules. The assay was evaluated in
duplicate. Satisfactory results were obtained for each dosage
form in a good agreement with the label claims (Table 7).
The results of the assay of SIL in Legalex Tablets were
statistically compared to those of the pharmacopoeial method,
BP method (British Pharmacopoeia, 2012), using the student’s
t-test and variance ratio F-test (Table 8). The experimental val-
ues of t-test and F-test did not exceed the theoretical ones,
thus, indicating the absence of any signiﬁcant difference be-
tween the compared methods.
4. Conclusion
A gradient HPLC method has been developed for the simulta-
neous determination of Silymarin and Curcumin in their dos-
age forms. The advantages of the proposed method over the
previously reported ones is the use of a DAD detector which
is widely available in the ordinary laboratories, with no need
for the more sophisticated mass or ﬂuorescence detectors. An-
other noted advantage is its stability-indicating power and itsPlease cite this article in press as: Korany, M.A. et al., A validated stability-
and Curcumin in various dosage forms. Arabian Journal of Chemistry (2ability to selectively analyze the studied drugs in the presence
of their forced degradation products.
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